Ensaios Clínicos

Últimos ensaios

Em recrutamento

• OP-1250-301 (OPERA-01)

A Phase 3 Randomized, Open-Label Study of OP-12...

A Phase 3, Randomized, Double-blind, Placebo- a...

• 20210098 FORTITUDE-102

A Phase 1b/3 Study of Bemarituzumab Plus Chemot...

Em implementação

• MK-3475-051

A Phase I/II Study of Pembrolizumab (MK-3475) i...

• MK-2870-019

A Phase 3 Randomized Open-Label Study of Adjuva...

• MK-1026-011/BELLWAVE-011

A Phase 3, Randomized Study to Compare Nemtabr...

Recrutamento encerrado

• XL184-315 – CONTACT -02

A Phase 3, Randomized, Open-Label, Controlled S...

• YO42137 SKYSCRAPER-07

A Phase III, Randomized, Double-Blind, Placebo-...

• C4221026 FLOTILLA

Encorafenib/Binimetinib Master Protocol: An Ope...